Rasagiline Mesylate
Overview
Rasagiline Mesylate is a selective, irreversible monoamine oxidase-B inhibitor used in the treatment of Parkinson's disease. It helps to increase and sustain the levels of dopamine in the brain, thus improving motor symptoms associated with the disease.
API suppliers (14)
Suppliers of Rasagiline Mesylate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 11 of 14 suppliers.
9 of 14 hold a GMP certificate on record in the EU or UK registers
- MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
- Amino Chemicals LtdMalta1 active DMF GMP on record
- Alkem Laboratories LimitedIndia1 active DMF GMP on record
- INDOCO REMEDIES LTDIndia1 active DMF GMP on record
- Torrent PharmaceuticalsIndia1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- TAI HENG INDUSTRY CO LTD1 active DMF
- EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan1 active DMF
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
- Micro Labs Usa1 active DMF
- Sun Pharmaceutical Industries LimitedIndia GMP on record
- Apotex Pharmachem India Pvt. Ltd.India
- Teva Pharmaceutical Industries Ltd.Israel GMP on record
Therapeutic areas
Do you supply Rasagiline Mesylate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.